Your browser doesn't support javascript.
loading
Curaxin CBL0137 has the potential to reverse HIV-1 latency.
Jean, Maxime J; Zhou, Dawei; Fiches, Guillaume; Kong, Weili; Huang, Huachao; Purmal, Andrei; Gurova, Katerina; Santoso, Netty G; Zhu, Jian.
Afiliação
  • Jean MJ; Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York.
  • Zhou D; Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
  • Fiches G; Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
  • Kong W; Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
  • Huang H; Department of Medicine, Columbia University Medical Center, New York, New York.
  • Purmal A; Division of Chemistry, Incuron LLC, Buffalo, New York.
  • Gurova K; Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, New York.
  • Santoso NG; Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
  • Zhu J; Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
J Med Virol ; 91(8): 1571-1576, 2019 08.
Article em En | MEDLINE | ID: mdl-30989696
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ativação Viral / Carbazóis / Infecções por HIV / HIV-1 / Latência Viral Limite: Humans Idioma: En Revista: J Med Virol Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ativação Viral / Carbazóis / Infecções por HIV / HIV-1 / Latência Viral Limite: Humans Idioma: En Revista: J Med Virol Ano de publicação: 2019 Tipo de documento: Article